GWN Securities Inc. bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 390 shares of the semiconductor company’s stock, valued at approximately $189,000.
A number of other large investors also recently made changes to their positions in the company. Gallacher Capital Management LLC increased its stake in shares of Synopsys by 10.4% during the fourth quarter. Gallacher Capital Management LLC now owns 467 shares of the semiconductor company’s stock worth $227,000 after purchasing an additional 44 shares during the period. Choate Investment Advisors increased its stake in Synopsys by 18.6% during the 4th quarter. Choate Investment Advisors now owns 497 shares of the semiconductor company’s stock worth $241,000 after acquiring an additional 78 shares during the period. Natixis Advisors LLC increased its stake in Synopsys by 5.2% during the 4th quarter. Natixis Advisors LLC now owns 180,720 shares of the semiconductor company’s stock worth $87,714,000 after acquiring an additional 9,012 shares during the period. M & L Capital Management Ltd bought a new position in Synopsys during the 4th quarter worth $21,623,000. Finally, Picton Mahoney Asset Management increased its stake in Synopsys by 4.7% during the 4th quarter. Picton Mahoney Asset Management now owns 31,489 shares of the semiconductor company’s stock worth $15,285,000 after acquiring an additional 1,425 shares during the period. Institutional investors own 85.47% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have commented on SNPS shares. Robert W. Baird lowered their price objective on Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Rosenblatt Securities reiterated a “buy” rating and issued a $660.00 price target on shares of Synopsys in a research note on Tuesday, February 25th. Piper Sandler decreased their price target on Synopsys from $655.00 to $653.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Needham & Company LLC reissued a “buy” rating and set a $650.00 price objective on shares of Synopsys in a report on Thursday, February 27th. Finally, Redburn Atlantic initiated coverage on Synopsys in a report on Monday, January 13th. They set a “buy” rating and a $600.00 price objective on the stock. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $638.58.
Synopsys Trading Down 1.2 %
Shares of SNPS opened at $447.99 on Wednesday. The company has a market capitalization of $69.27 billion, a PE ratio of 30.85, a PEG ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a 12 month low of $425.73 and a 12 month high of $624.80. The stock’s 50-day moving average price is $494.15 and its two-hundred day moving average price is $507.35.
Insiders Place Their Bets
In other news, CEO Sassine Ghazi sold 11,366 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the transaction, the chief executive officer now directly owns 70,922 shares of the company’s stock, valued at $32,890,077.50. The trade was a 13.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Geus Aart De sold 15,705 shares of the business’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the transaction, the insider now directly owns 116,671 shares in the company, valued at $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 47,909 shares of company stock valued at $22,794,835. 0.62% of the stock is currently owned by company insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- What is the Dow Jones Industrial Average (DJIA)?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Must-Own Stocks to Build Wealth This Decade
- 3 Warren Buffett Stocks to Buy Now
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.